Bessemer Group Significantly Boosts Q1 Stakes in ETFs, Walmart, Medline, and Medtronic

Bessemer's position in the iShares MBS ETF (MBB) increased to 1,596,964 shares in Q1, up 98,161 from the prior period, a 6.5% rise that equates to about 0.40% of the ETF.
Bessemer's Walmart stake reached 4,312,421 shares after adding 65,445 in the quarter, and Walmart became one of its notable holdings (the 19th largest).
Medline (MDLN) position was expanded to 3,504,006 shares after adding 3,495,136 in the quarter, with the stake valued at about $155.93 million.
Insider activity at Medline included Douglas P. Golwas selling 100,000 MDLN shares on June 16 at an average price of $36.77, reducing his ownership to 23,899 shares (an about 80.71% decrease).
In Medtronic (MDT), EVP Harry Skip Kiil sold 4,189 shares on June 8, leaving him with 37,227 shares valued at roughly $2.995 million, a 10.11% decrease in ownership.
Bessemer Group Inc. made one of its boldest portfolio moves in Q1 by nearly doubling its position in Medline Industries (MDLN), adding about 3.5 million shares for a total of 3,504,006 — a staggering 39,400% increase — valued at roughly $156 million, according to Watchlist News.
The firm also quietly expanded several other holdings. Its Walmart stake rose to 4.31 million shares, and its iShares Core S&P 500 ETF position grew to roughly 1.03 million shares worth about $671 million. The moves signal a broad, confident push across both equities and funds.
Bessemer's Medline position went from nearly nothing to 3,504,006 shares in a single quarter. The firm added 3,495,136 shares, making the stake worth about $155.93 million, according to Watchlist News. That kind of jump — 39,400% — is rare for an institutional investor of Bessemer's size and suggests a strong conviction buy.
But even as Bessemer bought in, insiders were selling. Douglas P. Golwas sold 100,000 MDLN shares on June 16 at an average price of $36.77. That cut his ownership from about 124,000 shares to just 23,899 — an 80.71% drop in his personal stake.
Bessemer raised its Medtronic (MDT) position by 16.6% in Q1, reaching about 4.75 million shares valued at roughly $412 million, per Ticker Report. The firm added around 676,000 shares to get there. Medtronic is a major medical device company, and the buy signals continued confidence in the healthcare sector.
Bessemer also added 65,445 Walmart shares, bringing its total to 4,312,421 — a 1.5% increase. Walmart is now the 19th largest holding in the firm's portfolio, making up about 0.8% of its total investments. At Medtronic, EVP Harry Skip Kiil sold 4,189 shares on June 8, leaving him with 37,227 shares worth about $2.995 million — a 10.11% personal ownership decrease.
Bessemer's iShares MBS ETF (MBB) stake climbed 6.5% to 1,596,964 shares after the firm added 98,161 shares. The firm now holds about 0.40% of the entire ETF. MBB tracks mortgage-backed securities — essentially bonds tied to home loans — giving Bessemer exposure to the U.S. housing debt market.
The firm's iShares Core S&P 500 ETF (IVV) stake grew 6.3% to about 1.03 million shares, valued near $671 million. Separately, its Vanguard Growth ETF (VUG) position rose 11.3% to 364,752 shares worth $159.32 million, according to Watchlist News. Together, these ETF moves show Bessemer is hedging individual stock risk with broad market exposure.
Not every move was a buy. Bessemer cut its IBM stake by 8.3% in Q1, bringing it to 770,200 shares — though that position is still worth about $186.70 million, per Ticker Report. IBM is a legacy tech giant, and the trim may reflect a shift toward faster-growing names.
On the other side, Bessemer boosted its Cisco Systems (CSCO) stake by 35.5% in the same quarter, according to Ticker Report. That is a large jump for a firm of Bessemer's size and points to growing interest in network infrastructure. The contrast with the IBM cut suggests the firm is rotating within tech — away from legacy hardware and toward networking.
Publishers
24
Articles
33
Reach
57